indinavir (crixivan) Report issue

Small molecule Approved FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

VA Big4

$0.9294 - $1.8689

VA FSS

$1.2474 - $2.4948

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
indinavir sulfate 200 mg (CAPSULE) $0.9294 VA Big4
  • CRIXIVAN (360)
    		•  Merck Sharp & Dohme Corporation
    indinavir sulfate 200 mg (CAPSULE) $1.2474 VA FSS
  • CRIXIVAN (360)
    		•  Merck Sharp & Dohme Corporation
    indinavir sulfate 400 mg (CAPSULE) $1.8689 VA Big4
  • CRIXIVAN (180)
    		•  Merck Sharp & Dohme Corporation
    indinavir sulfate 400 mg (CAPSULE) $2.4948 VA FSS
  • CRIXIVAN (180)
    		•  Merck Sharp & Dohme Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue